Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Biomedicines|November 11, 2022
Immunotherapy against the Cystine/Glutamate Antiporter xCT Improves the Efficacy of APR-246 in Preclinical Breast Cancer ModelsGiuseppina Barutello, Antonino Di Lorenzo, Alessandro Gasparetto, et al.
International Journal of Molecular Sciences|March 15, 2018
Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs' Revolution for ImmunotherapyGiuseppina Barutello, Valeria Rolih, Maddalena Arigoni, et al.
Journal of Translational Medicine|July 3, 2017
CSPG4: a prototype oncoantigen for translational immunotherapy studiesValeria Rolih, Giuseppina Barutello, Selina Iussich, et al.
Oncotarget|April 23, 2016
A hypoxic signature marks tumors formed by disseminated tumor cells in the BALB-neuT mammary cancer modelAichi Msaki, Anna Pastò, Matteo Curtarello, et al.
Angiogenesis|March 20, 2012
A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumorsMaddalena Arigoni, Giuseppina Barutello, Stefania Lanzardo, et al.
Molecular Aspects of Medicine|December 4, 2024
Cancer vaccines: Target antigens, vaccine platforms and preclinical modelsFrancesca Ruzzi, Federica Riccardo, Laura Conti, et al.
Oncoimmunology|February 6, 2018
A Virus-Like-Particle immunotherapy targeting Epitope-Specific anti-xCT expressed on cancer stem cell inhibits the progression of metastatic cancer in vivoElisabetta Bolli, John P O'Rourke, Laura Conti, et al.
European Journal of Cancer (Oxford, England : 1990)|October 23, 2013
DNA vaccination against membrane-bound Kit ligand: a new approach to inhibiting tumour growth and angiogenesisCristina Olgasi, Patrizia Dentelli, Arturo Rosso, et al.
Cancer Immunology, Immunotherapy : CII|June 28, 2018
Fighting breast cancer stem cells through the immune-targeting of the xCT cystine-glutamate antiporterRoberto Ruiu, Valeria Rolih, Elisabetta Bolli, et al.
Cancers|March 6, 2021
Identification of TENM4 as a Novel Cancer Stem Cell-Associated Molecule and Potential Target in Triple Negative Breast CancerRoberto Ruiu, Giuseppina Barutello, Maddalena Arigoni, et al.
Pageof 3